Literature DB >> 3097823

Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells.

A Yarden, A Kimchi.   

Abstract

The suppression of the c-myc nuclear oncogene is associated with growth arrest and may therefore be directly controlled by naturally occurring growth inhibitors. The effect of tumor necrosis factor (TNF) and of interferon-gamma (IFN-gamma) on c-myc expression was investigated in HeLa cells, which respond to these cytokines by a specific arrest in the G0/G1 phase of the cell cycle. Northern blot and nuclear transcription analyses indicated that each cytokine reduced within 1 to 3 hours the c-myc messenger RNA levels as a result of transcriptional inhibition. Adding the two cytokines together at saturating levels resulted in enhanced inhibition of c-myc transcription and of the c-myc messenger RNA steady-state levels. While the reduction of c-myc messenger RNA by IFN-gamma was dependent on new protein synthesis, the inhibitory effect of TNF on c-myc messenger RNA was direct and was not abrogated by cycloheximide. The differential effect of the protein synthesis inhibitor and the cooperative inhibitory effects of the two cytokines when added together suggest that IFN-gamma and TNF reduce c-myc transcription through different molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097823     DOI: 10.1126/science.3097823

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  24 in total

1.  Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest.

Authors:  N Tiefenbrun; D Melamed; N Levy; D Resnitzky; I Hoffman; S I Reed; A Kimchi
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis.

Authors:  A Kimchi; D Resnitzky; R Ber; G Gat
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

3.  Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin.

Authors:  J A Elias; R C Krol; B Freundlich; P M Sampson
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.

Authors:  R E Kiernan; S Emiliani; K Nakayama; A Castro; J C Labbé; T Lorca; K Nakayama Ki; M Benkirane
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells.

Authors:  K M Manchester; W D Heston; D B Donner
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

6.  Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes.

Authors:  R Zechner; T C Newman; B Sherry; A Cerami; J L Breslow
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

7.  Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.

Authors:  C Fady; A Gardner; J F Gera; A Lichtenstein
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

8.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

9.  Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells.

Authors:  G P Dupont; T P Huecksteadt; B C Marshall; U S Ryan; J R Michael; J R Hoidal
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

10.  Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells.

Authors:  D Resnitzky; N Tiefenbrun; H Berissi; A Kimchi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.